- Tytuł:
- Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.
- Autorzy:
- Źródło:
- Lancet. 6/30/2012, Vol. 379 Issue 9835, p2439-2448. 10p.
Czasopismo naukowe